Biobank Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product {Equipment (Cryogenic Storage System, Alarm Monitoring Systems, Others), Media & Consumables}, By Application (Regenerative Medicine, Drug Discovery, and Others), By Region and Competition 2020-2030F

Market Overview

The Global Biobank Equipment Market, valued at USD 49.97 Billion in 2024, is projected to experience a CAGR of 5.80% to reach USD 70.08 Billion by 2030. Biobank equipment encompasses specialized instruments and systems essential for the comprehensive management of biological samples, including collection, processing, storage, and retrieval. This category typically includes ultra-low temperature freezers, automated liquid handlers, and advanced sample management software. The market's expansion is fundamentally driven by the escalating demand for biomedical research, the growing prevalence of chronic diseases necessitating extensive sample repositories for personalized medicine development, and continuous technological advancements in automation and cryogenic preservation techniques.

The increasing global biobanking activity underpins equipment demand. According to BBMRI-ERIC, in 2023, it interconnected approximately 400 biobanks and over 2,600 collections across 32 countries, serving 9,000 users, indicating significant infrastructure deployment. A notable challenge impeding market expansion is the substantial initial capital investment required for establishing and maintaining modern biobank facilities.

Key Market Drivers

The increasing demand for personalized and precision medicine is a principal driver for the global biobank equipment market. This paradigm tailors medical treatments to individual patient characteristics, requiring extensive and diverse collections of high-quality biological samples. Biobanks provide these essential repositories, facilitating genomic sequencing, biomarker discovery, and targeted therapy development. The need for precise sample collection, processing, and long-term preservation directly elevates demand for specialized equipment, including advanced freezers and automated aliquotting systems. Regulatory approvals reflect this trend; according to an article from the National Academies of Sciences, Engineering, and Medicine (NASEM), December 2023, "Precision Medicine: A National Academies Workshop", 12 new molecular entities approved by the FDA in 2023 were considered precision medicine, highlighting the expanding application of targeted treatments.

Technological innovations in biobanking automation and storage significantly influence market expansion by enhancing efficiency and reliability in sample management. The growing volume of biospecimens collected for research and clinical trials mandates automated solutions to minimize human error, improve traceability, and ensure sample integrity. Advancements encompass robotic systems for sample handling, automated liquid handlers, and integrated software solutions to optimize high-throughput workflows. These innovations are critical for laboratories; according to an article published by SelectScience, October 2024, "SLAS Europe 2024: Key Trends in Laboratory Automation", 70% of laboratories reported plans to increase their investment in laboratory automation solutions over the next two years. This sustained investment in infrastructure further underscores market vitality, as according to a press release from the European Commission, November 2023, "European Research Area (ERA) Investment Package Announcement", over €50 million has been allocated to enhance research infrastructure across Europe, with a portion dedicated to upgrading biobanking facilities and acquiring advanced equipment.

Download Free Sample Report

Key Market Challenges

The substantial initial capital investment required for establishing and maintaining modern biobank facilities represents a notable challenge to the growth of the Global Biobank Equipment Market. Developing a state-of-the-art biobank necessitates significant financial resources for acquiring specialized instruments, advanced cryogenic storage systems, and sophisticated sample management software. This high upfront cost creates a considerable barrier for numerous entities, including smaller research institutions and emerging biotechnology companies, that may lack the extensive budgets needed to initiate or upgrade their biobanking operations.

This financial impediment directly hampers market expansion by restricting the proliferation of new biobank facilities and limiting the scale of modernization efforts in existing ones. The considerable expense involved deters potential investors and organizations from committing to new projects, thereby reducing the overall demand for essential biobank equipment. For instance, according to the International Society for Biological and Environmental Repositories (ISBER), in 2024, over 75% of biobank operational costs were associated with long-term sample storage. Such high operational costs, coupled with initial setup expenses, underscore the significant financial burden, directly influencing purchasing decisions for new and advanced equipment and consequently slowing market penetration.

Key Market Trends

Two significant trends currently driving growth in the Global Biobank Equipment Market are the integration of artificial intelligence and machine learning in equipment, and the expansion of cloud-based biobank data management. These trends are distinct from each other and represent crucial advancements in optimizing biobanking operations.

AI and machine learning integration in biobank equipment is enabling intelligent systems for enhanced operational efficiency and predictive capabilities. These algorithms optimize sample tracking, ensure precise quality control, and facilitate complex data analysis, directly improving biospecimen integrity and utility for research. This advancement allows biobanks to manage extensive datasets, uncover subtle patterns, and accelerate biomarker discovery. According to an announcement from Financial Post in September 2025, BenchSci partnered with Thermo Fisher Scientific to develop AI-powered research tools aimed at enhancing R&D productivity. This technological shift is also evident broadly; according to the Office for National Statistics in March 2025, artificial intelligence was adopted by 9% of UK firms in 2023, with a projected rise to 22% in 2024.

The expansion of cloud-based data management solutions is fundamentally reshaping how biobank samples and their associated information are stored, accessed, and shared. Cloud platforms provide superior scalability, security, and accessibility, facilitating distributed research collaborations and efficient data utilization while reducing the need for extensive on-premise infrastructure. This shift enhances data integrity, improves disaster recovery, and streamlines regulatory compliance. A significant transition was made by UK Biobank, which, as reported in July 2024, moved to a cloud-based Research Analysis Platform, supported by US$10 million in cloud computing credits from Amazon Web Services. This mirrors wider industry adoption; according to the Office for National Statistics in March 2025, 69% of UK firms utilized cloud-based computing systems and applications in 2023.

Segmental Insights

The Drug Discovery segment is experiencing rapid growth within the Global Biobank Equipment Market, establishing itself as the fastest-growing application. This expansion is primarily driven by the segment's critical role in advancing pharmaceutical research and development. Biobanks are indispensable repositories providing researchers with extensive access to diverse biological samples, essential for compound screening, biomarker identification, and rigorous clinical trial support. The increasing investments in pharmaceutical research and development, coupled with a surging demand for novel and precise therapeutic compounds, necessitate robust biobanking infrastructure. Furthermore, a growing emphasis on precision drug development and adherence to standardized storage protocols, often encouraged by regulatory bodies, further fuel the demand for specialized biobank equipment.

Regional Insights

North America leads the Global Biobank Equipment Market, primarily due to its robust healthcare infrastructure, which features advanced research facilities and well-established biotechnology firms. The region benefits from substantial public and private sector investments in biomedical sciences, genomics, and personalized medicine initiatives, exemplified by programs like the National Institutes of Health's research efforts. Furthermore, North America possesses a mature and supportive regulatory framework, including federal policies such as the Health Insurance Portability and Accountability Act (HIPAA) and the Common Rule, which ensure secure and ethical biobanking operations. This comprehensive ecosystem fosters high demand for specialized biobank equipment and advanced solutions.

Recent Developments

• In September 2025, Thermo Fisher Scientific launched a new generation of ultra-low temperature storage systems. This product introduction aims to improve the long-term stability and integrity of biological samples within biobanks and various research laboratories. The enhanced storage capabilities of these systems are critical for advancing research and clinical applications that rely on high-quality, well-preserved biospecimens. This development by Thermo Fisher Scientific signifies an advancement in essential equipment for the global biobank market, addressing the evolving needs for sample preservation.

• In May 2024, Hamilton Storage Technologies, Inc. announced the installation of four high-capacity Hamilton BiOS® automated storage systems at UK Biobank's new headquarters. These systems are designed to enhance the facility's capability to efficiently store and manage millions of biological samples. The deployment supports UK Biobank's role as a comprehensive health data source, enabling researchers globally to access de-identified biological data for understanding disease causes and accelerating discoveries of new treatments. This integration of advanced automated storage equipment directly contributes to optimizing operations within the global biobank equipment market.

• In May 2024, Sartorius expanded its multidisciplinary collaboration with NVIDIA to integrate artificial intelligence into drug discovery and manufacturing processes. This partnership involves leveraging NVIDIA's computing platforms and software within Sartorius' instruments, including their live-cell imaging platforms. The initiative focuses on developing predictive AI models of stem cell-derived organoids to improve drug discovery and precision medicine. This collaboration underscores breakthrough research in applying advanced computing to biopharmaceutical workflows, directly impacting the technologies and equipment utilized within the broader biobank and life sciences equipment sector.

• In January 2024, Brooks Automation announced the rebranding of its Brooks Life Sciences Services and Products businesses as Azenta Life Sciences. This strategic move aimed to unify its offerings, integrating genomics and analytical expertise with storage automation and informatics services. The new brand focuses on providing comprehensive, end-to-end sample exploration and management solutions for life science organizations globally. This strategic repositioning enhances the company's commitment to delivering advanced automated ultra-cold sample storage and management, directly influencing the competitive landscape and technological advancements in the global biobank equipment market.

Key Market Players

• Becton, Dickinson and Company
• Bio-Techne Corporation
• Hamilton Company
• Merck KgaA
• Lonza Group AG
• QIAGEN N.V.
• Stemcell Technologies Inc.
• Tecan Group AG
• Thermo Fisher Scientific Inc

Report Scope:

In this report, the Global Biobank Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Biobank Equipment Market, By Product:

o   Equipment (Cryogenic Storage System, Alarm Monitoring Systems, Others)

o   Media & Consumables

• Biobank Equipment Market, By Application:

o   Regenerative Medicine

o   Drug Discovery

o   Others

• Biobank Equipment Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biobank Equipment Market.

Available Customizations:

Global Biobank Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Biobank Equipment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]